Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
China Dominating Global Tetraspecific Antibody Clinical Trials Development Landscape
March 21, 2023 08:25 ET
|
KuicK Research
Delhi, March 21, 2023 (GLOBE NEWSWIRE) -- China has emerged as a dominant force in the field of tetraspecific antibodies, leading the way in clinical trials and showing promising results in the...
China Cell Therapy Market Size Clinical Trials Companies Insight
March 21, 2023 08:24 ET
|
KuicK Research
Delhi, March 21, 2023 (GLOBE NEWSWIRE) -- China Cell Therapy Market Opportunity & Clinical Trials Insight 2028 Report Highlights: More Than 400 Cell Therapies Are In Clinical Trials In...
LAG3 Antibody Market Size Approved Drugs Clinical Trials Companies Insight
March 21, 2023 08:09 ET
|
KuicK Research
Delhi, March 21, 2023 (GLOBE NEWSWIRE) -- Global LAG-3 Inhibitor Market, Drug Sales, Price & Clinical Trials Insight 2028 Report Highlights: • Global LAG-3 Inhibitor Drug Market Opportunity...
Tumor Infiltrating Lymphocyte TIL Therapy Market Size Clinical Trials Companies Insight
March 21, 2023 08:02 ET
|
KuicK Research
Delhi, March 21, 2023 (GLOBE NEWSWIRE) -- Tumor infiltrating lymphocyte (TIL) therapy is an emerging field in cancer immunotherapy. As researchers all over the world are conducting clinical trials...
CD47 Inhibitors Drugs Cancer Therapy Clinical Trials Market Size Companies Insight
March 21, 2023 07:49 ET
|
KuicK Research
Delhi, March 21, 2023 (GLOBE NEWSWIRE) -- Global CD47 Inhibitor Drug Clinical Trials Insight 2028 Report Highlights: CD47 Inhibitor Drug Market Trends & Future ProspectsInsight On More...
CD3 Antibodies Clinical Trials Market Size Companies Insight
March 21, 2023 04:27 ET
|
KuicK Research
Delhi, March 21, 2023 (GLOBE NEWSWIRE) -- Antibodies have transformed cancer treatment because of their flexible properties that allow them to be used as both antagonists and agonists. With the...
CD137 Antibodies Clinical Trials Market Opportunity Insight
March 21, 2023 03:56 ET
|
KuicK Research
Delhi, March 21, 2023 (GLOBE NEWSWIRE) -- Advancement in cancer immunology and recent clinical evidence have suggested that there is an urgent need to move towards new immunotherapeutic approaches...
China Cell Therapy Market Size Clinical Trials Companies Insight
March 20, 2023 07:45 ET
|
KuicK Research
Delhi, March 20, 2023 (GLOBE NEWSWIRE) -- China Cell Therapy Market Opportunity & Clinical Trials Insight 2028 Report Highlights: More Than 400 Cell Therapies Are In Clinical Trials In...
Bispecific Antibodies Market Size USD 30 Billion Sales Opportunity
March 20, 2023 07:28 ET
|
KuicK Research
Delhi, March 20, 2023 (GLOBE NEWSWIRE) -- Antibodies have been used as a therapeutic tool for quite some years for the treatment of several diseases the outcomes of which seen over the years have...
Advent Of Tetraspecific Antibodies In Cancer Therapy
March 20, 2023 07:21 ET
|
KuicK Research
Delhi, March 20, 2023 (GLOBE NEWSWIRE) -- In recent years, the pharmaceutical industry has shown a significant interest in developing novel antibody based therapies for the treatment of cancer....